This event has completed.

2/8/2023
8:00 AM - 5:00 PM EST

SCHEDULE
8:00 am – 9:00 am
Registration and Continental Breakfast

9:00 am –10:00 am 
The Nuances of Normal Tension Glaucoma
Justin Schweitzer, OD, FAAO
The most important risk factor for glaucoma is elevated intraocular pressure, however, the pressure theory cannot sufficiently explain how normal tension glaucoma causes vision loss. This course will discuss all aspects of normal tension glaucoma including the pathophysiology, diagnosis and treatment. 1 Hour IOB and Legend Drug

10:00 am – 12:00 pm
Innovations in Glaucoma: Next Generation Technology, Medications, and Delivery
Justin Schweitzer, OD, FAAO
Advances in glaucoma diagnostics and management continue to evolve at a rapid pace. In order to continue to care for glaucoma patients at a high level, it is imperative that innovation continues in the glaucoma space. The focus of this course is to discuss new advancements in glaucoma diagnostic technology, what’s new in the glaucoma pipeline, and what the future holds. 2 Hours IOB and Legend Drug

12:00 pm – 1:00 pm
Lunch included for ODs

1:00 pm –3:00 pm
VA Grand Rounds
​Anthony DeWilde, OD
This course highlights the interesting, often challenging, patients encountered at a VA Medical Center. Various conditions will be presented with an emphasis on posterior segment and systemic disease. Audience participation is encouraged. 2 Hours IOB and Legend Drug

3:00 pm – 4:00 pm
What a Pain! An Optometrist’s Guide to Headaches
​Anthony DeWilde, OD
Many patients come to the eye doctor concerned that headaches are related to their eyes. This course is designed to highlight important diagnostic strategies for optometrists to diagnose and manage patients with headaches to help determine which headaches originate from ocular conditions and which headaches can have ocular manifestations. 1 Hour IOB and Legend Drug

4:00 pm – 5:00 pm
Slaying the Giant! Diagnosis and Management of Giant Cell Arteritis
​Anthony DeWilde, OD
Giant cell arteritis (GCA) is an immune-mediated vasculitis with serious ophthalmic manifestations, including Arteritic Ischemic Optic Neuropathy (AION), Central Retinal Artery Occlusion (CRAO), and diplopia. It is important for the clinician to understand the signs and symptoms of GCA and how they relate to the eye. 1 Hour IOB and Legend Drug

Schedule subject to change. Should any scheduling changes be necessary, they will be posted on the webpage.

Questions? Contact the IOA at 317-237-3560 or education@ioa.org.